The relationships of body size and gestational age at birth with adult blood pressure (BP) are relatively modest compared to their stronger associations with cardiovascular disease. BP reactivity is a strong predictor of cardiovascular morbidity, and it is possible that reactivity, rather than resting level, is determined in utero. We investigated whether body size and gestational age at birth predict BP reactivity during experimentally induced psychosocial stress in late adulthood. A total of 73 men and 80 women born after 36 weeks' gestation in Helsinki, Finland, during 1934-1944 underwent the Trier Social Stress Test (TSST); a standardized psychosocial stress test consisting of a public speech and an arithmetic task. Changes in BP were monitored continuously by a non-invasive finger photoplethysmography (Finometer, FMS, Amsterdam, The Netherlands). The results showed that the most robust early determinant of BP reactivity was gestational age; however, with opposite relationships between the sexes (P for interaction o0.001). A 1-week increase in gestational age was associated with a 3.1 mm Hg (95% confidence interval (CI), 0.2 to 6.0) and 1.2 mm Hg (95% CI, À0.1 to 2.6) decreases in systolic and diastolic BP reactivity in women, but with 5.2 mm Hg (95% CI, 1.9 to 8.4) and 2.3 mm Hg (95% CI, 0.9 to 3.8) increases in men. In conclusion, normal variation in gestational age at birth predicts cardiovascular stress reactivity in later adulthood. Given that hypothalamic-pituitary-adrenal axis contributes to the regulation of autonomic nervous system function and the timing of parturition, and shows well-established sex differences, we speculate a role for early programming of this axis in explaining the findings.
Introduction
It is well established that elevated blood pressure (BP) in adulthood is associated with smaller body size at birth and shorter length of gestation. [1] [2] [3] However, the magnitude of these associations is relatively modest -BP increases approximately 2 mm Hg per kg decrease in birth weight, and o1 mm Hg per 1-week decrease in the length of gestation. [2] [3] [4] This is in marked contrast with much stronger relationships between smaller body size at birth and prevalence of overt hypertension, 5 coronary heart disease [6] [7] [8] and stroke, 9 and also in contrast with the recently reported associations of shorter length of gestation with stroke 10 and cerebrovascular disease. 11 One possible explanation for this discrepancy is that, rather than the absolute level of BP, it is cardiovascular reactivity that is associated with small size at birth and shorter length of gestation. Cardiovascular reactivity has several detrimental consequences for human health: high BP reactivity has been linked to hypertension, 12 increased left ventricular mass, 13 carotid atherosclerosis 14 and all-cause mortality. 15 Data from experimental rat models have shown that prenatal malnutrition 16 and prenatal stress, 17 potential determinants of smaller body size at birth and shorter length of gestation, are associated with exaggerated cardiovascular reactivity to restraint stress. In humans, we are aware of only two studies that have examined whether BP reactivity in adult life is predicted by body size or gestational age at birth. A study in young adults showed that smaller body size at birth predicts exaggerated BP and heart rate (HR) reactivity to psychological stressors in women but not in men. 18 BP and HR reactivity were not predicted by length of gestation in either women or men. However, both cardiac and vascular determinants of BP and HR reactivity are modified by age. 19, 20 Thus, it is not known whether these findings in young adults can be generalized to samples varying in age. A study in 56-to 61-year-old individuals born during or just after the Dutch World War II famine showed an association between lower birth weight and higher BP responsiveness, 21 but again generalizing from these findings is difficult because of the extreme conditions associated with the famine.
With this background, we set out to study whether smaller body size at birth and shorter length of gestation predict exaggerated cardiovascular reactivity during experimentally induced psychological stress in late adulthood. Because BP and HR responses to psychological stressors are characterized by clear and consistent sex differences, 18, 21, 22 and because the previous finding relating body size at birth with BP and HR reactivity was confined to young adult women, 18 we studied the effects separately in men and women.
Methods

Participants
The participants were from the Helsinki Birth Cohort Study, which consists of men (n ¼ 4630) and women (n ¼ 4130) who were born at Helsinki University Central Hospital during 1934-1944, attended child welfare clinics in the city of Helsinki, and were still resident in Finland in the year 1971, when personal identification numbers were allocated to all residents of the country. Details of the birth cohort have been described elsewhere. 8 During the years 2001-2004, at the average age of 61.5 years (s.d. ¼ 2.9, range ¼ 56.7-69.8), a subset of 2003 women (n ¼ 1075) and men (n ¼ 928) participated in a clinical examination. They were selected from the initial study population using random number tables as described recently. 8 From those who had attended the clinical examination and who had appropriate early life data including length of gestation and measurement of body size at birth available, 287 women and men participated in an experimental stress protocol between 2004 and 2005. Because of our focus on the life span consequences of slow intrauterine growth, we over represented by 33% participants whose birth weight adjusted for gestational age was below the 10th percentile of the entire birth cohort. The subjects were invited in random order. Continuous monitoring of BP was added to the experimental stress protocol when the non-invasive beat-to-beat monitor became available and was performed for the last 164 consecutive subjects. Valid data were obtained for 153 (93.3%) women (n ¼ 80) and men (n ¼ 73). For 11 subjects, the BP measurement was stopped before the end of experiment. The sample with the continuous BP data available did not differ from the rest of the sample in body size at birth (all P-values for birth weight, length, head circumference and ponderal index (PI) were 40.1), length of gestation (P ¼ 0.7), or body mass index (BMI; P ¼ 0.8). The study protocol was approved by the Ethical Committee of Epidemiology and Public Health Research at the Helsinki University Central Hospital. Written informed consent was obtained from each participant and the study was approved by an institutional review committee.
Neonatal characteristics
Data on newborn's date of birth, weight (g), length (cm), head circumference (cm) and the date of the mother's last menstrual period, as well as childhood social class (lower, 74.0%; lower middle, 19.6%; upper 6.5%), based on the father's occupation, were extracted from birth records and school health-care records. PI was calculated as (birth weight in kg)/ (birth length in m) 3 .
Clinical visit
The subjects reported at the clinic between 0945 and 1300 h. They were instructed to abstain from caffeine, cigarettes and eating for 2 h before arrival. On arrival, their body weight was measured to the nearest 0.1 kg in light indoor clothing without shoes. For height and for educational attainment in adulthood (middle school, 34.5%; vocational school, 15.5%; senior high school, 36.2%; college/university degree, 13.8%), we used data obtained during the previous visit to the clinic 1.9 years before (s.d. ¼ 0.8, range 0.6-3.5 years). 8 BMI was calculated as (weight in kg)/(height in m)
2 . An intravenouscatheter was inserted for blood sampling. Participants filled in a questionnaire enquiring whether they had ever had coronary heart disease, stroke, myocardial infarction, hypertension, panic disorder, diabetes, depression or asthma diagnosed by a physician. In addition, they were asked to report any unusual events before the arrival to stress test, such as their current mood, as well as the frequency of smoking and alcohol intake the previous evening.
Experimental stress protocol
After filling in all questionnaires and resting for a total of 45 min, the subject was led to the laboratory. The subject remained standing throughout the baseline and the experimental stress protocol and the time in between them. A continuous beat-to-beat monitoring of BP and HR during the baseline and the task was conducted by Finometer (FMS, Amsterdam, The Netherlands), non-invasive finger photoplethysmography. On average, systolic BP (SBP) and diastolic BP (DBP) measured by Finometer differ o2 mm Hg from those measured by mercury sphygmomanometer, whereas the Association for the Advancement of Medical Instrumentation criteria for the reliability of BP measurements require a bias of o5 mm Hg and a variability of o8 mm Hg against a mercury sphygmomanometer. 23, 24 Finometer also estimates systemic haemodynamic function by Modelflow method, 25 which computes an aortic flow waveform by simulating a non-linear three-element model of the aortic input impedance. This provides an estimate of left ventricular stroke volume, cardiac output (CO; calculated as stroke volume Â instantaneous HR and expressed as l/min) and total peripheral resistance (TPR; calculated as (mean arterial pressure/CO) Â 80 and expressed as dynes s cm À5 ). Rather than absolute values, in particular, relative changes in BP and stroke volume levels within an individual over time are most reliably measured by the Finometer device. 26, 27 Throughout the experiment, we controlled for that the hand position was stable. After the baseline recording, the subjects were exposed to a standardized experimental stress protocol known as Trier Social Stress Test (TSST). At the start of the TSST, the subject is asked to convince a committee of two persons (one man and one woman, who are dressed in white medical coats) for 5 min that he/she is the best candidate for a self-selected confidential post. To maximize the ego involvement, the subject is specifically asked to focus on his/her personal abilities and not to any objectively measurable quantities such as working experience. The assistant shows the subject a video camera and tape recorder and tells them that their performance is to be videotaped and recorded for further expert analysis of their behaviour and success in the task. The subject is told to prepare the speech for 3 min. The subject stands in front of the seated committee who are instructed to minimize all verbal and non-verbal communication during the preparation period and the speech task. A mental arithmetic task follows immediately after the speech task. The subject remains standing and is asked to perform serial subtractions, starting from 509 and subtracting seven. The subtractions are asked to be performed as fast as possible. If a mistake occurs, the committee notifies the subject by saying 'error' and asks him/ her to start again from 509. Although the arithmetic task and speech task both last for 5 min, the durations of the tasks are not revealed to the subject. After the completion of both tasks, all monitoring devices are removed and the subject is led to another room for the recovery period. As TSST is a very powerful stressor, all the subjects undergo a brief debriefing session after the task with a trained psychology student, who is also a committee member. The training for TSST was done under the supervision of Professor Hellhammer in the Department of Psychobiology at the University of Trier, where the protocol has been developed. A meta-analysis of 208 laboratory stress tests concluded that while the TSST also elicits the most robust hypothalamus-pituitary-adrenal axis (HPAA) response, produced by components of social evaluative threat, unpredictability and combination of speech task and cognitive task, 28 the repeatability of sympathetic nervous system response to TSST has shown even more consistency. 29 Other studies have also concluded that speech tasks with a similar evaluative board produce strong and moderately stable BP responses, which vary between individuals. 30, 31 Statistical analysis The data were screened for outliers. Birth weight (range 2290-4920 g), length, PI or head circumference adjusted for sex and length of gestation, nor length of gestation (range 253-307 days) did not exceed73 s.d.s, from the mean for any of the participants.
The data from Finometer were analysed with Beatscope software (version 1.1; Finapres Medical Systems, Amsterdam, The Netherlands). Beatscope generates a continuous trace from the beat-to-beat values, which is then used to aggregate task and baseline values. Following this, reactivity scores are determined as the increment from baseline to the mean level during the task. Aggregating BP and HR values across tasks produces the best estimate of dispositional stress reactivity of an individual. 32 The associations of body size at birth and length of gestation with cardiovascular (BP, HR, TPR and CO) stress reactivity were tested using multiple linear regression analyses. Although age, current BMI and childhood social class were not related to BP, HR, TPR or CO reactivity in our sample (all P-values 40.2, data not shown), they were further included as covariates in the regression models as BMI and age are known to be associated with BP and HR levels and reactivity and social class with birth size and gestational age. The use of b-blockers (n ¼ 14 for men and n ¼ 19 for women) had no effect on the BP reactivity in our sample (all P-values 40.2, data not shown), but it attenuated almost all of the variability in HR reactivity (the use of b-blockers was associated with 8.8 beats/min; 95% confidence interval (CI), 4.3-13.3; lower HR reactivity). However, as b-blockers inhibit sympathetic activity, we analysed the BP data by both including and excluding participants who were taking b-blockers, whereas all the HR analyses were conducted only among those participants not on b-blocking medication. Similarly, as TPR and CO are partly constructed from HR values, they were investigated only among those participants not on b-blocking medication. The use of antihypertensive medication (diuretics, calcium blockers, angiotensin-converting enzyme (ACE) blockers or angiotensin II blockers; n ¼ 64) was not associated with BP reactivity (P-values for SBP and DBP reactivity 40.05). In addition, the use of antihypertensive medication was not associated with HR, TPR and CO reactivity after participants on b-blocking medication were removed from analyses (all P-values 40.5).
Cardiovascular reactivity was unrelated to history of coronary heart disease (n ¼ 12), hypertension (n ¼ 56), panic disorder (n ¼ 2), asthma (n ¼ 11), smoking (n ¼ 29), performance during mental arithmetic task or level of education in adulthood (all P-values 40.1, data not shown), whereas BP reactivity was related to the use of depression medication. In women, the use of depression medication (n ¼ 5) was associated with 21.1 mm Hg (95% CI, À3.9 to 38.3; P ¼ 0.02) lower SBP reactivity and 9.3 mm Hg (95% CI, 1.2-17.3; P ¼ 0.03) lower DBP reactivity. Similarly, in men, the use of depression medication (n ¼ 5) was marginally related to lower SBP reactivity of 14.7 mm Hg (95% CI, À0.6 to 30.0; P ¼ 0.06). Also the use of lipid-lowering medication (statins) was associated with BP reactivity, such that participants taking statins had 12.5 mm Hg (95% CI, 5.7-19.4; Po0.01) higher SBP reactivity and 3.9 mm Hg (95% CI, 0.6-7.2; P ¼ 0.02) higher DBP reactivity. Therefore, we used age, current BMI, childhood social class, the use of b-blockers and the baseline CV value as additional covariates in the full regression model in our analyses. Alternative models were constructed with and without adjustment for BMI because of recent concerns of overinterpretation of BMI-adjusted relationships with perinatal variables. 33 Proportional differences were evaluated with Pearson's w 2 -test.
Results
Birth and current characteristics of the study sample are shown in Table 1 . Men participating in the TSST were older than women, and were born with a larger head circumference. Although there were more men with low birth weight (o2500 g), birth weight as a continuous measure was not different between sexes. There were also more men with diagnosed coronary heart disease. Baseline CV values did not differ between sexes, but men had higher CO reactivity than women, whereas women had higher TPR reactivity than men. There were no other significant gender differences in the study variables. The table also shows that TSST produced substantial BP and HR responses. BP increased in every participant from the baseline. As shown in Table 2 , birth weight was unrelated to BP reactivity in women. In men, lower birth weight was significantly related to lower DBP reactivity; however, this relationship disappeared after adjustment for gestational age. Table 3 shows that the most robust predictor of BP reactivity for both men and women was gestational age. In women, a 1-week increase in gestational age was associated with a 3.1-mm Hg (95% CI, 0.2-6.0) decrease in SBP reactivity (adjusted for age, current BMI, weight at birth, baseline value of SBP, childhood social class and the use of b-blocker medication measured at the time of TSST). A similar pattern, though marginally significant, was observed with DBP reactivity and HR reactivity. In men, SBP and also DBP reactivity were predicted by gestational age, but the direction was opposite to that of women. A 1-week increase in the length of gestation was associated with a 5.2-mm Hg (95% CI, 1.9-8.4) increase in SBP and a 2.3-mm Hg (95% CI, 0.9-3.8) increase in DBP reactivity. The relationships were linear and graded as depicted in Figure 1 , and the interaction term 'gestational age Â sex' was statistically significant in the analyses of BP reactivity (Table 3) .
Following this, we investigated relationships with CO and TPR values. CO reactivity was not associated with birth weight (Table 2 ) or gestational age (Table 3) in either women or men. Furthermore, TPR reactivity was neither associated with birth weight in women or men (Table 2 ) nor with gestational age in women (Table 3 ). However, gestational age was positively associated with TPR reactivity in men, such that 1-week increase in gestational age was associated with a 3.7-dynes-s-cm À5 (95% CI, 0.8-6.7) increase in TPR reactivity. Interaction term 'gestational age Â sex' was marginally significant in the analysis of TPR reactivity (Table 3) .
We repeated all analyses after exclusion of those participants diagnosed with stroke, diabetes and coronary heart disease (a total of 37 subjects). The results remained similar. Furthermore, when participants taking b-blocking medication were excluded from the analyses, the results of gestational age and SBP reactivity in women remained marginally significant (SBP reactivity, P ¼ 0.09), whereas in men they remained significant (SBP reactivity, Po0.001; DBP reactivity, P ¼ 0.002). Including depression medication, antihypertensives, statins or educational attainment in adulthood in the models did not change the results. Leaving current BMI out from the fully adjusted models did not change the BP and TPR results in men. In women, the relationships remained similar for SBP reactivity (P ¼ 0.03), and the regression coefficients for DBP reactivity were À1.1 mm Hg (95% CI À2.4 to 0. No other measure of size at birth (length at birth, head circumference or PI) was a significant predictor of BP, HR, TPR or CO reactivity in men or in women (all P-values 40.05, data not shown).
Discussion
Our study shows that normal biological variation in the length of gestation at term predicts cardiovascular stress reactivity at the ages of B60 years. However, the effects differ between women and men. Women born earlier exhibited exaggerated BP and HR reactivity in response to psychological stress. In contrast, men born earlier had lower BP reactivity and TPR reactivity in response to psychological stress. Our associations of 3.1-mm Hg-increase in SBP reactivity per 1 week of gestational age in women were strong in comparison to comparable associations of o1 mm Hg per 1 week with resting SBP. 2, 3 The associations were independent of the baseline BP levels and possible confounding factors including age, current BMI, childhood social class and the use of b-blocking medication. Low birth weight or other anthropometric measurements obtained at birth were not independently related to cardiovascular reactivity to psychological stress in this study.
Our findings contrast with previous findings showing associations between low birth weight and increased BP reactivity at least in women. 18, 34 For example, Ward et al. 18 showed that lower birth weight predicted exaggerated BP and HR responses to psychological stressors in young adult women. In their study, however, lower birth weight did not predict cardiovascular reactivity in men, and Interaction term sex Â gestational age as a predictor for BP, HR, CO or TPR reactivity.
Cardiovascular reactivity and gestational age K Feldt et al gestational age was unrelated to cardiovascular reactivity in either women or men. Similarly, Painter et al. 21 studied 56-to 61-year-old subjects exposed to the Dutch famine and showed that high BP responsiveness was predicted by exposure to famine in early gestation and, regardless of famine exposure, with lower birth weight in women. In men, the relationship was opposite. The effects of gestational age were not reported in that study. However, the studies differ in several methodological respects. We applied the TSST, whereas the study of Ward et al. 18 and Painter et al. 21 employed cognitive challenges together with a hypothetical confrontational scenario. Although the former is a potent stimulator of the adrenocortical response and therefore produces a predominantly 'vascular' a-adrenergic pattern of reactivity to stress, the latter gives rise to a greater badrenergic 'cardiac' response. 35 More importantly, the study of Ward et al. 18 that reported a lack of association with gestational age at birth differs markedly in the age of the participants. BP responses in that study, and also in a study of young healthy individuals in response to TSST, 36 were lower than those in our study and increasing age is accompanied by alterations in responses to acute stress: BP responses are increased especially in women, 22 and parasympathetic withdrawal 19 as well as increases in plasma norepinephrine spillover 20 become more pronounced. Our findings are supported, however, by observations that earlier gestational age also within its normal variation is associated with adverse cardiovascular health outcomes such as the resting BP level in adult women 2 and mortality from cerebrovascular disease. 37 Together with previously described associations of BP reactivity with both resting BP level 38 and magnetic resonance imaging-diagnosed subclinical cerebral infarctions and related findings, 39 our findings suggest that these associations of pre-and perinatal conditions with adult disease are probably in part explained by associations with BP reactivity.
In men, we found that lower gestational age was related to lower BP and TPR reactivity. These associations were not explained by any known medical disorders. We have no ready explanation for the findings in men, but they may again relate to the relatively old age of the men studied. Currently, there are few studies in this age group that have accurate gestational age and adult BP measurements available. While an inverse association between gestational age and resting BP in men has been described in two studies of young military conscripts, 3, 40 the few data available in middle-aged men have shown discrepant results. [41] [42] [43] This discrepancy along with our results could partly be confounded by greater premature adult mortality of men who were born at an earlier gestational age. However, the strong sex differences in our study might also be explained by hormonal interference. Testosterone is suggested to upregulate neuropeptide Y, 44 which is a potent vasoconstrictor. Interestingly, testosterone has also been shown to enhance the contractile effects of endothelin-1 in porcine coronary artery rings, an effect attenuated by oestrogen. 45 Whether the peripheral interference of sex hormones explains also the sex differences also in this study remains to be established. Such an effect would, however, be of significant potential clinical relevance as it is suggested that especially among hypertensive patients the BP responses to stress are driven peripherally rather than centrally, 46 and among the elderly hypertension is characterized by increased vascular resistance and reduced CO. 47 However, until further studies are performed, these explanations remain speculative.
The overall association between gestational age and BP reactivity suggests involvement of physiological processes, which determine both the timing of delivery and BP regulation. Placental corticotrophin releasing hormone (CRH) and fetal glucocorticoids are key regulators of the timing of delivery. 48 The length of gestation has been linked with maternal plasma CRH levels, 49 and stress-related pretermdelivery is thought to be mediated by changes in CRH and glucocorticoid secretion. 50, 51 There is good evidence that prenatal glucocorticoid exposure alters not only the development of the HPAA but also sympathetic innervation 52 and cardiac noradrenergic and sympathetic processes. 53 It is therefore possible that the associations between gestational age and altered BP reactivity reflect prenatal alterations in fetal glucocorticoid exposure and resulting phenotypic differences in the neuroendocrine responses to stressors. This hypothesis is supported by previous findings in the Helsinki Birth Cohort Study suggesting that gestational age at birth has an important modifying effect on the association between body size at birth and HPAA function in adulthood. 54, 55 The involvement of HPAA might also account for the marked sex differences in our data as the patterns of programming of HPAA and autonomic responses are highly sex specific in many species. 56 There are a few limitations to our study. Although the determination of gestational age by the date of last menstrual period has been validated against fetal ultrasound, 57 it may introduce inaccuracy and thus any potential effect relating to gestational age has to be robust and statistically strong. This might also be the reason why there are relatively few reports on long-term effects of gestational age in adults born at term. In addition, the uncertainties of gestational age determination by last menstrual period are mostly related to pre-or post-term deliveries, 57 whereas the vast majority of our subjects were born at term, that is, between 37 and 42 weeks of gestation. As generations who have undergone routine assessment of gestational age by first or second trimester ultrasound are now entering adulthood, and first-trimester assessment is becoming routine in many health-care systems, more studies testing these hypotheses will be available. A particular limitation of our study is that we did not have sufficient data of the BP levels or possible diagnosis of pre-eclampsia of the mothers, which may all be associated with fetal growth, length of gestation and perhaps with the development of fetal vascular tree.
In summary, this study provides evidence for the hypothesis that exaggerated cardiovascular reactivity may be determined in utero. Since the HPAA is known to be involved in the regulation of autonomic nervous system function, BP and the timing of parturition, and shows well-established sex differences, we speculate a role of early programming of this axis in explaining this finding. We suggest that in similar studies both the gender of the subjects and the peripheral and central components should be investigated separately. Moreover, our result highlights the role of gestational age at birth as a potential marker of intrauterine conditions in birth cohort studies.
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